Subtype
Uterine Corpus Neoplasm
CI-CAN-00007035Explore in graph →
Non-malignant451 active trials4 approved drugs28 evidence items
- NCIt
- C6300
Loading cancer entity…
Subtype
CI-CAN-00007035Explore in graph →
Clinical trials
1,714 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00217633 | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | completed | Phase 2 | 38 | Gynecologic Oncology GroupNETWORK | 2 | May 29, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01379534 |
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer |
| completed |
| Phase 2 |
| 53 |
| Novartis PharmaceuticalsINDUSTRY |
| 7 |
| May 20, 2015 |
| clinicaltrials |
| NCT00006011 | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | completed | Phase 3 | 659 | Gynecologic Oncology GroupNETWORK | 1 | May 19, 2015 | clinicaltrials |
| NCT01810874 | STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer(STELLA) | completed | N/A | 60 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02086370 | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques(Rad_PBS) | completed | N/A | 177 | University Magna GraeciaOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00072176 | Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Feb 23, 2015 | clinicaltrials |
| NCT00122343 | AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) | completed | Phase 2 | 45 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 19, 2015 | clinicaltrials |
| NCT00389974 | Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Feb 16, 2015 | clinicaltrials |
| NCT00507741 | Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) | completed | Phase 2 | 49 | EndocyteINDUSTRY | 0 | Jan 7, 2015 | clinicaltrials |
| NCT00005830 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | completed | Phase 1 | 31 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00005840 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | completed | Phase 1 | 35 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00104910 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 64 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00814086 | Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | completed | Phase 1 | 23 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00068549 | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | completed | Phase 1 | 13 | Gynecologic Oncology GroupNETWORK | 1 | Dec 25, 2014 | clinicaltrials |
| NCT02049242 | Uterine Tourniquet at Open Myomectomy | completed | N/A | 48 | Ataturk UniversityOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02086279 | AMH Levels Change During Treatment With GnRh Agonist | completed | N/A | 67 | University Magna GraeciaOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT00388154 | Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT00870337 | Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer(ENDORAD) | completed | Phase 2 | 44 | ARCAGY/ GINECO GROUPOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00515073 | Papillary Serous Carcinoma of the Endometrium | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 3, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00495235 | Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas | completed | — | 147 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00295945 | Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer | completed | — | 240 | University of California, San FranciscoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT01364844 | Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors | completed | Phase 1 | 42 | Daiichi SankyoINDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00485355 | Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy | completed | N/A | 27 | The Cleveland ClinicOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00002493 | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | completed | Phase 3 | — | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00087100 | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00030485 | Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00703807 | Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers | completed | Phase 1 | 10 | Yale UniversityOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00085332 | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 5 | Jan 13, 2014 | clinicaltrials |
| NCT00003749 | Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | completed | Phase 3 | 2,300 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01079832 | Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies | completed | Phase 2 | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01965080 | Exemestane in Advanced and Recurrent Endometrial Carcinoma | completed | Phase 2 | 52 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 1 | Oct 18, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00002949 | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | completed | Phase 1 | 33 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00604994 | Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer(LEGS) | completed | — | 761 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00005583 | Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | completed | Phase 3 | 400 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 11 | Aug 2, 2013 | clinicaltrials |
| NCT01911247 | Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer | completed | Early Phase 1 | 28 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00003691 | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 3 | 240 | Gynecologic Oncology GroupNETWORK | 2 | Jul 9, 2013 | clinicaltrials |
| NCT00004082 | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | completed | Phase 1 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2015source: clinicaltrials